Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Bartholdy

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nature Medicine|September 8, 2015
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemiaBritta Will, Thomas O Vogler, Swathi Narayanagari, et al.
The Journal of Biological Chemistry|September 14, 2017
ZNF143 protein is an important regulator of the myeloid transcription factor C/EBPαDavid Gonzalez, Annouck Luyten, Boris Bartholdy, et al.
Cancer Cell|March 5, 2021
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanismKoki Ueda, Rajni Kumari, Emily Schwenger, et al.
Blood|June 23, 2012
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDSLaura Barreyro, Britta Will, Boris Bartholdy, et al.
Science Translational Medicine|April 13, 2018
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemiaLuis A Carvajal, Daniela Ben Neriah, Adrien Senecal, et al.
The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.
Cancer Cell|January 8, 2021
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment PersistenceEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Science Translational Medicine|March 9, 2022
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemiaLaura Barreyro, Avery M Sampson, Chiharu Ishikawa, et al.
Nature Chemical Biology|October 6, 2015
New IDH1 mutant inhibitors for treatment of acute myeloid leukemiaUjunwa C Okoye-Okafor, Boris Bartholdy, Jessy Cartier, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nature Medicine|September 8, 2015
Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemiaBritta Will, Thomas O Vogler, Swathi Narayanagari, et al.
The Journal of Biological Chemistry|September 14, 2017
ZNF143 protein is an important regulator of the myeloid transcription factor C/EBPαDavid Gonzalez, Annouck Luyten, Boris Bartholdy, et al.
Cancer Cell|March 5, 2021
MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanismKoki Ueda, Rajni Kumari, Emily Schwenger, et al.
Blood|June 23, 2012
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDSLaura Barreyro, Britta Will, Boris Bartholdy, et al.
Science Translational Medicine|April 13, 2018
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemiaLuis A Carvajal, Daniela Ben Neriah, Adrien Senecal, et al.
The Journal of Clinical Investigation|October 31, 2017
Pharmacological inhibition of the transcription factor PU.1 in leukemiaIléana Antony-Debré, Ananya Paul, Joana Leite, et al.
Cancer Cell|January 8, 2021
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment PersistenceEugen Dhimolea, Ricardo de Matos Simoes, Dhvanir Kansara, et al.
Science Translational Medicine|March 9, 2022
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemiaLaura Barreyro, Avery M Sampson, Chiharu Ishikawa, et al.
Nature Chemical Biology|October 6, 2015
New IDH1 mutant inhibitors for treatment of acute myeloid leukemiaUjunwa C Okoye-Okafor, Boris Bartholdy, Jessy Cartier, et al.
Pageof 3